Hepatotoxicity of antituberculosis drugs.
Open Access
- 1 February 1996
- Vol. 51 (2) , 111-113
- https://doi.org/10.1136/thx.51.2.111
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- A controlled trial of six months chemotherapy in pulmonary tuberculosis: First report: Results during chemotherapyPublished by Elsevier ,2004
- Hepatotoxicity caused by the combined action of isoniazid and rifampicin.Thorax, 1995
- Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitisTubercle and Lung Disease, 1994
- Fatal hepatotoxicity of anti-tubercular chemotherapyThe Lancet, 1991
- The management of pulmonary tuberculosis in adults notified in England and Wales in 1988Respiratory Medicine, 1991
- Inter-relations between relapses, drug regimens and compliance with treatment in tuberculosisRespiratory Medicine, 1991
- Ocular toxicity from ethambutol.Thorax, 1986
- Deaths occurring in newly notified patients with pulmonary tuberculosis in England and WalesRespiratory Medicine, 1984
- Adverse Effects of Antituberculosis DrugsDrugs, 1982
- Effect of Rifampicin and Isoniazid on Liver FunctionBMJ, 1972